Immutep (IMMP) Exchange Rate Effect (2016 - 2024)

Immutep (IMMP) posted Exchange Rate Effect of -$186541.5 for Q2 2024, up 5.72% on a QoQ basis from -$197860.1 in Q2 2023, and up 5.72% year-over-year from -$176447.8 in Q3 2023.

Immutep (IMMP) Exchange Rate Effect (2016 - 2024) Analysis & Trends

Immutep's Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$186541.5 for Q2 2024.

  • Quarterly Exchange Rate Effect rose 5.72% year-over-year to -$186541.5 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$49977.7 (changed N/A YoY) and the FY2025 annual result came in at $4.3 million, up 775.43% from the prior year.
  • Exchange Rate Effect was -$186541.5 for Q2 2024 at Immutep, up from -$197860.1 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at -$186541.5 in Q2 2024 and bottomed at -$197860.1 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 619,347.27
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 19.32 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -40.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -900,000.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immutep 569.08 Mn 569.08 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -186,541.49
Jun 30, 2024 -186,541.49
Jun 30, 2023 -197,860.09
Jun 30, 2023 -197,860.09
Jun 30, 2017 407,726.92
Jun 30, 2017 407,726.92
Jun 30, 2016 -73,303.03
Jun 30, 2016 -73,303.03